Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Price Target at $166.00
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-three research firms that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has given a strong […]
More Stories
Sagicor Financial Company Ltd. (OTCMKTS:SGCFF) Short Interest Update
Sagicor Financial Company Ltd. (OTCMKTS:SGCFF – Get Free Report) was the target of a large growth in short interest during...
Sodexo S.A. (OTCMKTS:SDXOF) Short Interest Down 27.0% in December
Sodexo S.A. (OTCMKTS:SDXOF – Get Free Report) was the recipient of a large decline in short interest in December. As...
Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Down 49.3% in December
Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) was the target of a significant drop in short interest in December....
Abrdn Australia Equity Fund Inc (NYSEAMERICAN:IAF) Sees Significant Increase in Short Interest
Abrdn Australia Equity Fund Inc (NYSEAMERICAN:IAF – Get Free Report) was the recipient of a significant growth in short interest...
Faraday Copper Corp. (OTCMKTS:CPPKF) Short Interest Update
Faraday Copper Corp. (OTCMKTS:CPPKF – Get Free Report) was the recipient of a significant increase in short interest during the...
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Sees Significant Growth in Short Interest
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Free Report) saw a significant growth in short interest in December. As of December...